Waickman, A.T.; Lu, J.; Chase, C.; Fang, H.; McDowell, E.; Bingham, E.; Bogart, J.; Graziano, S.; Thomas, S.J.; Gentile, T.
Systemic Cancer Therapy Does Not Significantly Impact Early Vaccine-Elicited SARS-CoV-2 Immunity in Patients with Solid Tumors. Vaccines 2022, 10, 738.
https://doi.org/10.3390/vaccines10050738
AMA Style
Waickman AT, Lu J, Chase C, Fang H, McDowell E, Bingham E, Bogart J, Graziano S, Thomas SJ, Gentile T.
Systemic Cancer Therapy Does Not Significantly Impact Early Vaccine-Elicited SARS-CoV-2 Immunity in Patients with Solid Tumors. Vaccines. 2022; 10(5):738.
https://doi.org/10.3390/vaccines10050738
Chicago/Turabian Style
Waickman, Adam T., Joseph Lu, Corey Chase, Hengsheng Fang, Erinn McDowell, Erin Bingham, Jeffrey Bogart, Stephen Graziano, Stephen J. Thomas, and Teresa Gentile.
2022. "Systemic Cancer Therapy Does Not Significantly Impact Early Vaccine-Elicited SARS-CoV-2 Immunity in Patients with Solid Tumors" Vaccines 10, no. 5: 738.
https://doi.org/10.3390/vaccines10050738
APA Style
Waickman, A. T., Lu, J., Chase, C., Fang, H., McDowell, E., Bingham, E., Bogart, J., Graziano, S., Thomas, S. J., & Gentile, T.
(2022). Systemic Cancer Therapy Does Not Significantly Impact Early Vaccine-Elicited SARS-CoV-2 Immunity in Patients with Solid Tumors. Vaccines, 10(5), 738.
https://doi.org/10.3390/vaccines10050738
